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The expression of a hybrid gene containing the promoter egion of the mouse Ren- 1 or Ren-2 genes and the chloramphen- 
icol acetyl transferase (CAT) gene coding region was analysed in five cell lines that do not normally express the renin 
gene. The renin promoter is inactive in each of these cell lines unless the SW0 enhancer is also present in the construct. 
In the latter case, transcription initiates at the normal renin start site. This is in contrast to the situation observed in 
lymphoid cells where the renin promoter is inactive even when coupled to a functional enhancer [(1987) EMBO J. 6, 
168%1690]. Furthermore, S-flanking sequences of Ren-2, placed upstream of the thymidine kinase or SV40 early region 
promoters do not alter the activity of these promoters in three different cell lines. The results suggest hat, except for 
B cells, the renin promoter is not tissue-specific but that its lack of activity in cells that do not express the gene is not 
the result of repression but may be due to the absence in these cells of one or several Iruns-acting positive factors. 
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1. INTRODUCTION 
Promoters and enhancers constitute the two 
main classes into which the c&-acting elements re- 
sponsible for the specific expression of a eucaryotic 
gene in a given tissue, at a specific stage of develop- 
ment or in response to a given stimulus can be 
divided. The promoter is responsible for accurate 
initiation of transcription whereas the enhancer in- 
creases the rate of transcription from a promoter 
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which can be located as far as several kilobase pairs 
away. More recently, interactions of proteins with 
these c&acting DNA sequences have been describ- 
ed and some of the protein factors characterized. 
An important issue that remains to be addressed is 
how the different DNA elements and/or DNA- 
protein complexes that are involved in the specific 
expression of a gene interact with one another. 
The two renin genes of the mouse are particular- 
ly interesting in this respect. Designated by &n-l 
and Ren-2, they are both expressed mainly in the 
juxtaglomerular cells of the kidney and in the sub- 
maxillary gland (SMG) although lower expression 
in other extra-renal sites (testis, adrenals, ovaries, 
brain) has been reported [l-3]. Ren-1 and Rert-2 
are under the control of androgens and thyroxin in 
the SMG and Ren-2 which is present in only certain 
strains of mice is expressed at levels higher than 
those of Ren-1 by about two orders of magnitude 
in the SMG of both males and females. The prox- 
imal 5 ‘-flanking regions of both genes have been 
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sequenced [4,5] and comparison with the 
equivalent region of the unique renin gene of the 
rat, which is expressed only in the kidney, has 
yielded clues on the elements responsible for SMG 
expression and regulation by androgens (61. 
Moreover, essentially all the information necessary 
for proper expression of &n-2 is contained within 
a 16 kb fragment that includes 2.5 kb of 
5 ‘-flanking sequence, the entire coding region and 
3 kb of 3’-flanking sequences, as demonstrated by 
experiments with transgenic mice carried out in this 
laboratory [7]. Unfortunately, the absence of cell 
lines that normally express the renin gene has 
hindered the detailed analysis of the &acting 
elements involved in the differential expression and 
hormonal regulation of Ren-1 and Rem2. The 
present work is an effort to identify some of these 
elements using cell lines where renin expression is 
not spontaneously observed. It was previously 
demonstrated in this laboratory that the renin pro- 
moter is not functional in B lymphocytes even 
when coupled to an enhancer functional in these 
cells [8]. In the present work, we show that, in con- 
trast to what is seen in B cells, the renin promoter 
is functional in five other cell ines, provided that 
an enhancer functional in the cell line is also includ- 
ed in the transfected construct indicating that the 
non-activity of the renin promoter alone is not due 
to the presence of a repressor. 
2. MATERIALS AND METHODS 
2.1. Plasmid construction 
The structure of the plasmids used in this work is partially 
schematized in fig.1. The R2 fragment was obtained from the 
recombin~t X phage SW 10 141. It consists of positions - 2500 
to + 7 (for numberings, see [9]) of Ren-2. It also carries posi- 
tions 5171-5235 of the SV40 virus immediately downstream of 
the renin sequences (fig.3). The Rl fragment and its deletions 
are described in [8]. Both R2 and RI fragments were subcloned 
into the unique restriction sites of pSB1 or pSBlSV [lo] to 
generate pRZCAT, pR2CATSV and pR1CATSV. The pSBlSV 
plasmid which contains theSV40 enhancer (PvuII-NcoI 1111) in
the unique BamHI site was used to make the negative control 
plasmid and pSB1 containing the SV40 early region promoter 
(the 342-bp PvuII-HindIII fragment corresponding to positions 
270-5171) subcloned in the Hind111 site was used to make the 
positive control. The 1025-bp UMS fragment (SacI-XbaI [12]) 
was kindly provided by P. Herbomel with Sa[I and X/r01 sites 
at its respective nds. It was subcloned into the Sal1 site of the 
above CAT plasmids to generate ptR2CAT, ptR2CATSV, 
ptRlCATSV, the negative control plasmid (ptCATSV) and the 
positive control plasmid (ptSVECAT). The plasmid 
ptd5CATSV which constitutes a deletion mutant of 
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prRlCATSV was constructed from the RS fragment described 
previously IS]. 
For the construction of plasmids containing the herpes 
simplex virus thymidine kinase (tk) promoter, the HindIII- 
SamHI fragment’of pTKCAT [ll] was isolated and ligated to 
the BarnHI-Hind111 fragment of ptCATSV to generate 
pttkCAT. BamHI linkers were ligated to the Hind111 end of the 
same fragment of pTKCAT, followed by ligation to the Barn&II 
fragment of ptR2CAT that contains the plasmid sequences, the 
UMS and R2 positions -2500 to - 117 thus generating 
ptR2tkCAT (fig.1). 
The plasmid ptR2SVECAT was constructed by subcloning 
the Hind111 fragment containing the SV40 early promoter of 
ptSVECAT into the unique Hind111 site of ptR2CAT and the 
plasmid ptR2tSVECAT was constructed by excision of the SalI- 
Hind111 fragment of ptR2CAT (UMS and R2 sequences), addi- 
tion of Sal1 linkers to the Hind111 end of this fragment and in- 
sertion into the SalI site of ptSVECAT. 
2.2. Cell culture, transfection and CAT assay 
Baby hamster kidney (BHK), mouse L, and human choriocar- 
cinema JEG-3 cell lines were grown in Dulbecco’s modified 
Eagle medium containing 10% fetal calf serum. Chinese 
hamster ovary (CHO) cells were grown in F12 medium sup- 
plemented with 10% fetal calf serum and cells of the human 
mammary tumor cell line T47D were grown in RPM1 1640 
medium with 10% fetal calf serum. About 7 x 10s cells were 
plated in 10 cm Petri dishes 24 h before transfection. All cells 
were transfected using the calcium phosphate procedure 1131, 
except for T47D cells which were transfected by the DEAE- 
dextran procedure 1141 or by elec~oporation at 210 V (3.8 mm 
electrode spacing) [15]. For CAT assays, cells were suspended in 
0.25 M Tris-HCl, pH 7.8, and lysed by successive cycles of 
freezing and thawing. CAT activity was assayed on 0.2-0.3 mg 
of cytosolic protein as described [16]. 
2.3. RNA preparation and primer extension analysis 
BHK cells were transfected with 10 pg of plasmid. They were 
collected 48 h later, rinsed with ice-cold phosphate-buffered 
saline and lysed on plates with 4 ml of: 4 M guanidinium thio- 
cyanate; 1 M @-mercaptoethanol; 20mM sodium acetate, pH 5. 
RNA was prepared by guanidinium isothiocyanate/lithium 
chloride precipitation followed by oligo (dT)-Sepharose 
chromatography as in [17]. 
A single strand probe corresponding to positions I-71 of the 
cut gene (downstream from the Hind111 site) was prepared ac- 
cording to the procedure previously described [S]. The poly(A)+ 
RNA was hybridized to 25000 cpm of the probe for 18 h at 
42’C in lop1 of hybridization buffer: 40 mM Pipes, pH 6.4; 
1 mM EDTA; 0.5 M NaCl and 50% formamide. Following 
precipitation, the hybrids were elongated with reverse transcrip- 
tase (Genofit) and analysed as described by [9] except that the 
4 dNTPs were present in the reaction mixture and that elongated 
hybrids were desalted by three successive steps of ethanol 
precipitation before being loaded onto a 6% sequencing el. 
3. RESULTS 
Constructs 
from Rev-1 or 
containing 5 ‘-flanking sequences 
Ren-2 (fig. 1) linked to the indicator 
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Fig. 1. Structure of the promoter fragments for the renin-CAT 
constructs. The above DNA fragments were subcloned into the 
SalI-Hind111 cloning sites of pSB1 or pSBISV [lo], immediately 
upstream of the cat coding sequences. UMS, upstream mouse 
sequence; R2, 2.5 kb of 5’-flanking sequence of Rem2; Rl, 
0.5 kb of 5’flanking sequence of Ren-1; A5, a deletion mutant 
of RI conserving positions - 142 to +30; tk, herpes simplex 
virus tbymidine kinase promoter positions - 200 to + 50; SVE, 
SV40 early promoter positions 270 to 5171 (342 nt). For details 
of the constructions, see section 2. 
gene CAT were transfected into five different cell 
lines that do not normally produce renin: baby 
hamster kidney (BHK) and L fibroblasts, Chinese 
hamster ovary (CHO) cells, the JEG-3 choriocar- 
cinema cell line and the human mammary tumor 
cell line T47D. Some of the constructs also contain- 
ed the SV40 enahncer [ 181. In transient expression 
Table 1 
Expression of renin-CAT hybrid genes in heterologous cell lines 
Plasmid Cell line 
L CHO BHK JEG-3 T47D 
ptR2CAT 0 
ptR2CATSV 
(0428) 
ptRICATSV 
(tz) 
ptA5CATSV ND 
0 0 0 0 
(& (0?4) 
0.6 
(0.3) (ll!) 
(Z) (042) (!Z) (0.:) 
(0.:) 
ND ND ND 
CAT activity was determined on 0.2-0.3 mg of cytosolic protein 
65 h after transfection. Numbers represent CAT activity ex- 
pressed as the percentage of the positive control plasmid 
(ptSVECAT). The absolute CAT activity expressed as the % of 
acetylated chloramphenicol during a 2-h incubation is given in 
parentheses. All values are the mean of two to four experiments. 
ND, not determined 
Fig.2. Expression of renin-CAT constructs in T47D cells. CAT 
activity was determined in extracts of T47D cells transfected 
65 h earlier with 20 ,ug of the indicated plasmids by electropora- 
tion. Each sample corresponds to 300 pg of cytosolic proteins. 
experiments, no CAT activity could be observed 
with the plasmids that only contained 2.5 kb of 
Ren-2 5 ‘-flanking sequence. However, constructs 
that contained both e SV40 enhancer and renin 
sequences (2.5 kb of Ren-2 or 0.5 kb of Ren-1) 
were active in each of the five cell lines that were 
tested (fig.2, table 1). The activity observed with 
the different plasmids expressed as a percentage of 
the positive control (ptSVECAT) varied according 
to the cell line but the absolute activity was always 
of the same order of magnitude. In four of the five 
cell lines, CAT activity obtained with ptR2CATSV 
was not significantly different from that obtained 
with ptR1CATSV. Only in T47D cells did the latter 
plasmid produce 10 times less activity than 
ptR2CATSV (table 1). In order to verify that the 
absence of CAT activity observed after transfec- 
tion of ptR2CAT is not due to the absence from 
this construct of a crucial c&acting element 
located elsewhere in the gene (introns, 3 ‘-flanking 
region), a plasmid carrying the entire Ren-2 gene 
(16 kb fragment; see section I and [8]) was trans- 
fected into T47D cells by electroporation and renin 
transcripts were tentatively detected 48 h later us- 
ing the extremely sensitive cDNA amplification 
243 
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procedure (Ekker et al., Proc. Natl. Acad. Sci. 
USA, in press) which derives from the polymerase 
chain reaction assay [19]. However, we could not 
detect any signal corresponding to a renin tran- 
script (not shown). Therefore, even the entire renin 
gene seems to be inactive following transfection in- 
to T47D cells. 
All hybrid constructs that were used in this work 
contain the UMS (upstream mouse sequence) ele- 
ment immediately upstream of the renin sequences 
(fig. 1) or at the equivalent position in positive and 
negative control plasmids. The UMS sequence 
originates from the upstream region of the mouse 
c-mos gene and has been shown to be a potent tran- 
scription terminator in eucaryotic cells [ 12,201. We 
have inserted this element in order to prevent back- 
ground CAT activity resulting from spurious tran- 
scripts originating in the procaryotic sequences of 
the vector [21]. Previous observations in this 
laboratory showed that plasmids containing only 
renin sequences (the same as those shown in fig.1) 
but without the SV40 enhancer nor the UMS had 
lower activities than the easily detectable activity of 
the negative control and that these activities in- 
creased when the renin sequences were progressive- 
ly deleted (unpublished observations). Such results 
could suggest he presence of a repressor-like ele- 
ment within the renin sequences. However, in this 
work, the negative control plasmid with UMS 
never produced any background CAT activity and 
reduction of the size of the renin sequences down to 
180 bp did not lead to a significant enhancement of 
74 
31 
+30 
(Ren-1) 
I 
CAT 
(67nt) 
PROBE 
REN-1 
REN-2 
Fig.3. Mapping of the transcription startpoints for ptRlCATSV (lane A) and ptR2CATSV (lane B) in BHK cells. RNA was prepared 
from cells 48 h after transfection. Primer extension analysis was performed as described in section 2. The primer extension strategy is 
depicted on the right. Thin line: renin sequences with their 3 ‘-end indicated by vertical arrows. Horizontal arrows indicate the start site 
and direction of transcription. The open box represents the cai coding region and the primer corresponds to cat positions i-71 with 
respect o the Hind111 site. In the &n-2 construct, the dark box represents SV40 positions 5171 to 5235 + linker. The presence of these 
sequences i  the result of the strategy used to prepare the R2 fragment. There is no AT0 codon in the viral sequences and these, which 
are also found in the positive control plasmid, do not interfere with CAT activity. However, the spot around t 29 in lane B is related 
to the presence of the SV40 sequences. The same spot is observed when the transcription startpoint is mapped for the positive control 
plasmid that contains the same sequences. It represents none of the SV40 early promoter start sites. 
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CAT activity as shown in table 1. Therefore, our 
previous observations can be best explained by 
non-specific initiation of transcription in the 
pBR322 sequences upstream of the renin fragments 
with decreased translatability into CAT protein of 
readthrough transcripts upon the insertion of long 
renin sequences. 
We determined the site of transcription initiation 
of the renin-CAT fusion genes (ptR2CATSV and 
ptRlCATSV) in BHK cells by primer extension 
analysis with an oligonucIeotide that corresponds 
to the 5’-end of the CAT gene coding region. Fig.3 
shows that the length of the extension products that 
were obtained indicating that initiation of tran- 
scription occurred at the normal startpoints of 
Ren-2 and Ren-1, respectively. Therefore, The 
Ren-1 and Ren-2 fragments that we have used do 
function as promoters in BHK cells provided that 
the SV40 enhancer is also present in the construct. 
We assume that this is also the case for CHO, L, 
JEG-3 and T47D cells. 
In order to identify elements within the 
5 ‘-flanking region of the mouse renin genes which 
have stimulatory effects on transcription, we plac- 
ed Rem2 sequences upstream of two well- 
characterized promoters that are known to func- 
tion in a wide variety of cell types. In a first series 
of experiments, we replaced nucleotides - 1 to 
- 117 of ptR2CAT (with respect o the renin tran- 
scription start of Ren-2) by the well-characterized 
thymidine kinase promoter of herpes simplex virus 
[23]. This plasmid (ptR2tkCAT) as well as the 
equivalent plasmid without renin sequences 
(pttkCAT) were transfected into T47D cells or into 
rat pituitary GC cells. No difference in CAT activi- 
ty could be observed between pttkCAT and 
ptR2tkCAT (table 2). Moreover, in GC cells in 
which regulation of growth hormone promoter ac- 
tivity by thyroid hormone has been demonstrated, 
the addition of 2.4 kb of renin sequences upstream 
of the tk promoter had no effect on the activity of 
the latter when the cells were grown in the presence 
of 10q9 M T3 (table 2). Similar results were obtain- 
ed in mouse L fibroblasts (table 2). The renin se- 
quences of ptR2CAT were also placed upstream of 
the SV40 early promoter (either directly upstream 
or separated by an UMS element). No significant 
effect of renin sequences on CAT activity could be 
seen after transfection in T47D cells. In fact, inser- 
tion of renin sequences upstream of the SV40 early 
Table 2 
Expression of ‘hybrid promoter’-CAT constructs 
Plasmid Cell line 
T47D GC L BHK 
pttkCAT 0.40 1.35 0.13 ND 
ptR2tkCAT 0.34 1.05 0.10 ND 
ptSVECAT 0.6 ND 1.9 10 
ptR2tSVECAT 1.3 ND 2.8 26 
ptR2SVECAT 3 ND 2.1 13 
CAT activjty was determined on 0.2-0.3 mg of cytosolic protein 
65 h after transfection. It is expressed as % of acetylated chlor- 
amphenicol during a 2-h incubation. Numbers are the mean of 
two to four experiments. ND, not determined 
promoter resulted in a slight increase in CAT ac- 
tivity (1-3-fold) and was also obtained in BHK or 
L fibroblasts. Thus, in two different series of ex- 
periments, we could not see any striking effect of 
Rem2 5 ‘-flanking sequences on the activity of a 
heterologous promoter nor could we observe ac- 
tivity of the thyroid hormone response element in 
cells that possess the appropriate receptor. 
4. DISCUSSION 
Tissue-specific expression of a number of genes 
is conferred by enhancer elements that have been 
localized in their vicinity. The immunoglobulin 
genes [24-271, the gene for insulin 1281, chymotryp- 
sin [28], the prolactin and growth hormone genes 
[29] and the 61-crystallin gene [30] represent only a 
few examples. In most of these cases, the enhancer 
was able to confer tissue specificity to a hetero- 
logous promoter. A direct role for promoter 
elements in tissue-specific expression has been 
demonstrated for immunoglobulin genes 
[26,31,32] and possibly insulin [33] and ar-feto- 
protein [34,35]. In the present work, we show that 
even though expression of the mouse renin genes is 
limited to a few tissues, i.e. mainly the juxta- 
glomerular cells of the kidney and the tubular cells 
of the submaxillary gland as well as a few other 
extra-renal sites, the promoters of Ren-1 and 
Ren-2, defined as the elements necessary for ac- 
curate initiation of transcription, do not function 
in a tissue-specific manner. Indeed, when coupled 
to the SV40 enhancer, the promoters of the two 
genes can direct transcription of the indicator CAT 
245 
Volume 255, number 2 FEBS LETTERS September 1989 
gene in BHK, L, CHO, JEG3 and T47D cells, 
none of which normally express the renin gene. A 
similar phenomenon has been described for other 
mammalian genes, including the lysozyme [36], 
con~bumin [18], al-crystallin [29]. The only cells 
where the renin sequences are inactive even when 
coupled to a functional enhancer are lymphoid 
cells [8]. In these cells, a renin promoter becomes 
active only after insertion of the conserved deca- 
nucleotide element which confers B-cell specificity 
to the promoters of the immunoglobulin heavy and 
light chain genes. This effect of the decanucleotide 
seems to be limited to cells of the B lineage because 
constructions containing the decanucleotide are no 
more active than those with the original renin pro- 
moter in T3T cells [8], CHO and T47D cells (our 
unpublished observations). 
Promoter activity is obtained with fragments 
that span 2.5 kb of Ren-2 upstream sequence as 
well as 500 or 180 bp of Ren-1. Overall, the ac- 
tivities obtained with all fragments are roughly 
equal, that is reducing the size of the renin frag- 
ment does not lead to any significant increase in ac- 
tivity. Therefore it appears unlikely that an element 
with repressor-like properties is present within the 
upstream region of the renin genes and that tissue- 
specific control of renin gene expression is achieved 
through repression. The absence of CAT activity, 
when ptR2CAT is transfected into cells that do not 
normally express the renin gene, is then probably 
due to the absence from these cells of one or several 
trans-acting positive factor(s) f8,37]. 
The present experiments lead to the suggestion 
of a model for the transcriptional regulation of the 
renin gene. First, no constraints are put on the pro- 
moter, that is, the main factor is not whether tran- 
scripts can be initiated correctly in a given cell type 
but rather whether they can be initiated in suffi- 
cient numbers. This is consistent with expression of 
the renin genes in various extra-renal sites without 
necessity for very complex regulatory mechanisms 
(Ekker et al., Proc. Natl. Acad. Sci. USA, in 
press). Secondly, although not demonstrated here, 
the presence of an enhancer-like lement hat func- 
tions in a tissue-specific manner is probable. The 
renin genes are expressed in more than one cell type 
and thus the possibility of several distinct elements 
of this kind is not excluded. Assuming that one of 
these elements is present in the 5’-flanking region 
of the renin genes, its lack of effect on hetero- 
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Iogous promoters (tk, SV40; table 2) further sup- 
ports a possible tissue-specific activity. Finally, the 
enhancement of transcription resulting from the 
binding of an inducer-receptor complex to its 
target sequence could be dependent upon the prop- 
er function of the tissue-specific enhancer. Such 
mechanism would, for example, prevent unwanted 
increase of the transcription of the renin genes in 
other cells that are responsive to the inducer but do 
not normally produce renin. 
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